Tony Vernon

Track

Insider profile

Currently holds a position at McCormick & Company Inc

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 18% 8.2% 15.1%
Success rate 99% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director McCormick & Company Inc May 23, 2017 -
Tony Vernon's trades of Novocure Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Novocure Ltd (NVCR)
Transaction date
Sale
Price
143.11
Quantity 83,744 +35.1%
Value US$4,300,508
US Novocure Ltd (NVCR)
Transaction date
Sale
Price
238.64
Quantity 35,378 +10.0%
Value US$3,004,036
US Novocure Ltd (NVCR)
Transaction date
Sale
Price
431.07
Quantity 64,779 +27.1%
Value US$4,934,677
US Novocure Ltd (NVCR)
Transaction date
Sale
Price
91.03
Quantity 100,000 -38.7%
Value US$9,103,100
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-03 2026-06-02
US Novocure Ltd (NVCR)
S Sale
83,744 +35.1%
143.11
US$4,300,508 		83,744 +35.1% 143.11 US$4,300,508
2025-06-04 2025-06-03
US Novocure Ltd (NVCR)
S Sale
35,378 +10.0%
238.64
US$3,004,036 		35,378 +10.0% 238.64 US$3,004,036
2024-06-06 2024-06-04
US Novocure Ltd (NVCR)
S Sale
64,779 +27.1%
431.07
US$4,934,677 		64,779 +27.1% 431.07 US$4,934,677
2019-09-03 2019-08-29
US Novocure Ltd (NVCR)
S Sale
100,000 -38.7%
91.03
US$9,103,100 		100,000 -38.7% 91.03 US$9,103,100